CRT VALVE AORTIC: TAVR & PMVR: STATE OF THE FIELDS

Monday, March 10, 2025

8:00 AM - 11:45 AM ET

Moderator(s)

Maurice Buchbinder, MD, FSCAI

Medical Director
Foundation for Cardiovascular Medicine
San Diego, California, United States

No relationships to disclose
Thomas E. MacGillivray, MD

Physician Executive Director and Chair, Cardiac Surgery
MedStar Health, MedStar Washington Hospital Center
Washington, District of Columbia, United States

No relationships to disclose
Michael J. Reardon, MD

Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States

No relationships to disclose

Disclosure(s):

Maurice Buchbinder, MD, FSCAI: No financial relationships to disclose

Thomas E. MacGillivray, MD: No financial relationships to disclose

Michael J. Reardon, MD: BSCI: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); High Life: Consulting Fees (e.g., advisory boards) (Ongoing); JValve: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Siemens: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)